Activity value 75International Buyer&Supplier,Last transaction date:
2026-06-23
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for topfond pharmaceutical c0.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 14 transactions, with a transaction quantity of 23748.87 and a transaction weight of 0.1.
YearTransactionsQuantityWeight
20254381821.9432746.58
20261423748.870.1
Bill of lading data
<
1/15
>
Trade date
2026/06/23
B/L No.
108365795420
Suppliers
topfond pharmaceutical c0.ltd.
Buyers
công ty cổ phần armephaco
Product description
LINCOMYCIN HCL EP 11.0, 2000 Bou = 2301.8 Kg (Nguyên liệu sản xuất thuốc. Hàng mới 100%. Số lô: 251237060, 251237061, 260137001. HSD:2028. NSX: Topfond Pharmaceutical Co., Ltd - China)
Expand
Trade date
2026/05/18
B/L No.
108252615440
Suppliers
topfond pharmaceutical c0.ltd.
Buyers
công ty cổ phần dược đồng nai
Product description
ACETYLSPIRAMYCIN CP2025 (Dược chất sản xuất thuốc;20kg/thùng); Số lô:251231002 & 251231010 (NSX: T12/2025-HSD: T06/2029); 260131031;260131038;260131057 (NSX: T01/2026-HSD: T07/2029) (*). Hàng mới 100%
Expand
Trade date
2026/04/24
B/L No.
108183786320
Suppliers
topfond pharmaceutical c0.ltd.
Buyers
công ty cổ phần dược đồng nai
Product description
ACETYLSPIRAMYCIN CP2025 (Dược chất sản xuất thuốc); Số lô: 251131042; 251231070; 251231066; 251231064 & 251231029; NSX: T12/2025-HSD: T06/2029. Hàng mới 100%
Expand
Trade date
2026/04/03
B/L No.
108114831750
Suppliers
topfond pharmaceutical c0.ltd.
Buyers
công ty cổ phần dược đồng nai
Product description
NL sản xuất thuốc:ACETYLSPIRAMYCIN;CP2025;20kg/drum;lô:251231049;251231050;(NSX:15/12/2025 ;HD:14/06/2029);lô:251231065;NSX:19/12/2025;HD:18/06/2029;SĐK cũ VD-22574-15 và sđk mới:893115467224;mới 100%
Expand
Trade date
2026/03/31
B/L No.
108103584850
Suppliers
topfond pharmaceutical c0.ltd.
Buyers
công ty cổ phần dược vật tư y tế thanh hoá
Product description
LINCOMYCIN HCL EP 11.0, 2000 Bou = 2293.76 Kg (Nguyên liệu sản xuất thuốc. Hàng mới 100%. Số lô: 251137002, 251137003. HSD:2028. NSX: Topfond Pharmaceutical Co., Ltd - China)
Expand
Trade date
2026/02/27
B/L No.
108007599820
Suppliers
topfond pharmaceutical c0.ltd.
Buyers
công ty cổ phần dược đồng nai
Product description
Nguyên liệu sản xuất thuốc ( dược chất): LINCOMYCIN HYDROCHLORIDE. Tiêu chuẩn: EP 11. Số lô: 251037033,251037034 , nsx: 09.10.25, hsd: 08.10.28, dạng bột, 20BOU/drum. Mới 100%
Expand
Trade date
2025/12/25
B/L No.
107833187450
Suppliers
topfond pharmaceutical c0.ltd.
Buyers
công ty cổ phần hóa chất global hub
topfond pharmaceutical c0.ltd. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as ceftriaxone sodium,entercavir,neomycin sulphate.
According to the 52wmb.com global trade database, as of 2026-06-23, the company has completed 497 international trades,
with its main trading regions covering vietnam,pakistan,brazil etc.
The core products include HS29419000,HS29419090,HS29419021 etc,
often transported via shanghai,port shanghai cn, port zhengzhou etc,
and its main trading partners are pfizer pakistan limitedltd,farmabase saude animal ltd.,công ty cổ phần dược vật tư y tế thanh hoá.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on topfond pharmaceutical c0.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.